ClinicalTrials.Veeva

Menu

Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19 (STras-Cov-2)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Covid-19

Study type

Observational

Funder types

Other

Identifiers

NCT04681157
7754 (Other Identifier)

Details and patient eligibility

About

Odor and taste disturbances have increased dramatically during this time of the COVID-19 pandemic. Currently, we have very little information on the demographic and clinical characteristics of the affected population, on the severity and course of the olfactory / taste loss.

The main objective of this research is to analyze the epidemiological, demographic and clinical characteristics of patients suspected or already confirmed of infection with SARS-Cov2 presenting with anosmia and / or ageusia.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major subject (≥18 years old)
  • Subject having had a loss of smell and / or taste that occurred during the period of the Covid-19 epidemic with or without other symptom (s) suggestive of a Covid infection -19
  • Subject with suspected or confirmed Covid-19 infection
  • Subject taken care of by the ENT service
  • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

  • Subject having expressed opposition to participating in the study
  • Subject under guardianship or guardianship
  • Subject under safeguard of justice

Trial contacts and locations

1

Loading...

Central trial contact

Saïd CHAYER, PhD, HDR; Marion RENAUD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems